Making errors in Lu-177-Dota-(Tyr3)-Octreotate synthesis – still within QC specifications or not?

Katrimari Kiviluoto

Presentation information

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Radiopharmacy1

Technology

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-31-1] Making errors in Lu-177-Dota-(Tyr3)-Octreotate synthesis – still within QC specifications or not?

Katrimari Kiviluoto^1,2、Vappu Reijonen¹、Veera Ahtiainen¹ (1.Molecular Radiotherapy Unit, Helsinki University Hospital Comprehensive Cancer Center、2.HUS Pharmacy, Helsinki University Hospital)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

« Previous in this session
Next in this session »

▲

Presentation information

Radiopharmacy1

Technology

[WP-31-1] Making errors in Lu-177-Dota-(Tyr3)-Octreotate synthesis – still within QC specifications or not?

Password